All Stories

  1. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study

    Article • Journal of Hepatology, March 2015, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  2. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?

    Article • Expert Review of Anticancer Therapy, January 2015, Taylor & Francis

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  3. Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

    Article • Digestive and Liver Disease, October 2014, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  4. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C

    Article • Journal of Hepatology, September 2014, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  5. European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?

    Article • Future Oncology, August 2014, Future Medicine

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  6. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

    Article • Journal of Hepatology, August 2014, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  7. Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

    Article • Expert Review of Anticancer Therapy, May 2014, Taylor & Francis

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  8. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

    Article • Diagnostic and Interventional Radiology, May 2014, AVES Publishing Co.

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  9. EASL HCC summit: liver cancer management

    Article • Future Oncology, May 2014, Future Medicine

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  10. Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

    Article • Clinical Gastroenterology and Hepatology, May 2014, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  11. Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

    Article • Cancer, April 2014, Wiley

    PhD Giuseppe Cabibbo, Professor Edoardo G. Giannini, Dr GIUSEPPE CABIBBO

  12. Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

    Article • Hepatology, April 2014, Wolters Kluwer Health

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  13. O123 POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT

    Article • Journal of Hepatology, April 2014, Elsevier

    PhD Giuseppe Cabibbo

  14. P1009 THE HISTOLOGICAL OR ULTRASONOGRAPHIC DETECTION OF STEATOSIS AFFECTS THE PERFORMANCE OF LIVER STIFFNESS MEASUREMENT FOR FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION

    Article • Journal of Hepatology, April 2014, Elsevier

    PhD Giuseppe Cabibbo

  15. P965 PERSONALIZED THERAPY WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA

    Article • Journal of Hepatology, April 2014, Elsevier

    PhD Giuseppe Cabibbo

  16. Post sorafenib survival in patients with advanced hepatocellular carcinoma: The role of tumor progression and liver impairment

    Article • Digestive and Liver Disease, February 2014, Elsevier

    PhD Giuseppe Cabibbo

  17. The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection

    Article • Digestive and Liver Disease, February 2014, Elsevier

    PhD Giuseppe Cabibbo

  18. Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results

    Article • La radiologia medica, December 2013, Springer Science + Business Media

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  19. Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

    Article • Expert Review of Anticancer Therapy, December 2013, Taylor & Francis

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  20. Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C

    Article • Journal of Hepatology, October 2013, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  21. Rs4374383 single nucleotide polymorphism of MERTK gene influences the development of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis

    Article • Digestive and Liver Disease, October 2013, Elsevier

    PhD Giuseppe Cabibbo

  22. Personalized sorafenib therapy for hepatocellular carcinoma

    Article • Digestive and Liver Disease, October 2013, Elsevier

    PhD Giuseppe Cabibbo

  23. Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

    Article • Digestive and Liver Disease, October 2013, Elsevier

    PhD Giuseppe Cabibbo

  24. Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

    Article • Digestive and Liver Disease, October 2013, Elsevier

    PhD Giuseppe Cabibbo

  25. NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis

    Article • PLoS ONE, August 2013, PLOS

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  26. Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response

    Article • PLoS ONE, July 2013, PLOS

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  27. Rise and fall of HCV‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA.LI.CA centres

    Article • Liver International, June 2013, Wiley

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  28. Assessment of treatment response in hepatocellular carcinoma: a review of the literature

    Article • Future Oncology, June 2013, Future Medicine

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  29. Faculty Opinions recommendation of Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.

    Article • May 2013, F1000Research

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  30. Treatment of hepatocellular carcinoma: present and future

    Article • Expert Review of Anticancer Therapy, April 2013, Taylor & Francis

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  31. 262 SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IS AFFECTED BY COMPLETE RESPONSE TO RADIO-FREQUENCY THERMAL ABLATION (RFTA)

    Article • Journal of Hepatology, April 2013, Elsevier

    PhD Giuseppe Cabibbo

  32. Faculty Opinions recommendation of Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.

    Article • February 2013, F1000Research

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  33. Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

    Article • Hepatology, February 2013, Wolters Kluwer Health

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  34. T-38 Survival of patients with hepatocellular carcinoma (HCC) is affected by complete response to radio-frequency thermal ablation (RFTA)

    Article • Digestive and Liver Disease, February 2013, Elsevier

    PhD Giuseppe Cabibbo

  35. Faculty Opinions recommendation of Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

    Article • October 2012, F1000Research

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  36. Causes of and Prevention Strategies for Hepatocellular Carcinoma

    Article • Seminars in Oncology, August 2012, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  37. Faculty Opinions recommendation of Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.

    Article • July 2012, F1000Research

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  38. Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device—Initial observations

    Article • European Journal of Radiology, April 2012, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  39. Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation – authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, March 2012, Wiley

    PhD Giuseppe Cabibbo

  40. CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY

    Article • Digestive and Liver Disease, March 2012, Elsevier

    PhD Giuseppe Cabibbo

  41. OC-26 The emerging impact of HCC-NAFLD in Italy

    Article • Digestive and Liver Disease, February 2012, Elsevier

    PhD Giuseppe Cabibbo

  42. Faculty Opinions recommendation of Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

    Article • January 2012, F1000Research

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  43. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study

    Article • World Journal of Hepatology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  44. Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

    Article • Hepatology, December 2011, Wolters Kluwer Health

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  45. Should cirrhosis change our attitude towards treating non‐hepatic cancer?

    Article • Liver International, August 2011, Wiley

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  46. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

    Article • Alimentary Pharmacology & Therapeutics, May 2011, Wiley

    PhD Giuseppe Cabibbo

  47. OC-1 Prospective Italian multicenter field-practice study with sorafenib for advanced hepatocellular carcinoma

    Article • Digestive and Liver Disease, February 2011, Elsevier

    PhD Giuseppe Cabibbo

  48. Update on new approaches in the management of hepatocellular carcinoma

    Article • Hepatic Medicine Evidence and Research, November 2010, Taylor & Francis

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  49. Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

    Article • Digestive and Liver Disease, October 2010, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  50. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

    Article • Hepatology, December 2009, Wolters Kluwer Health

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  51. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis

    Article • Journal of Hepatology, October 2009, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  52. Cost-effectiveness of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

    Article • Digestive and Liver Disease, May 2009, Elsevier

    PhD Giuseppe Cabibbo

  53. 811 COST-EFFECTIVENESS OF RECALL STRATEGIES FOR NON-INVASIVE DIAGNOSIS OF SMALL HEPATOCELLULAR CARCINOMA

    Article • Journal of Hepatology, April 2009, Elsevier

    PhD Giuseppe Cabibbo

  54. 778 SURVIVAL OF UNRESECTABLE HEPATOCELLULAR CARCINOMA: A META-ANALYSIS OF THE CONTROL ARMS OF 28 RANDOMIZED TRIALS

    Article • Journal of Hepatology, April 2009, Elsevier

    PhD Giuseppe Cabibbo

  55. Prognostic scores for hepatocellular carcinoma: none is the winner

    Article • Liver International, March 2009, Wiley

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  56. Survival of unresectable hepatocellular carcinoma: A meta-analysis of the control arms of 28 randomized trials

    Article • Digestive and Liver Disease, March 2009, Elsevier

    PhD Giuseppe Cabibbo

  57. Multimodal approaches to the treatment of hepatocellular carcinoma

    Article • Nature Reviews Gastroenterology & Hepatology, February 2009, Springer Science + Business Media

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  58. Needle track seeding following percutaneous procedures for hepatocellular carcinoma

    Article • World Journal of Hepatology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  59. Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance

    Article • Digestive Diseases, January 2009, Karger Publishers

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  60. Meta-Analysis of the Placebo Rates of Clinical Relapse and Severe Endoscopic Recurrence in Postoperative Crohn's Disease

    Article • Gastroenterology, November 2008, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  61. Can Chemotherapy Concurrently Delivered to Radiotherapy Improve the Results of Radiotherapy as (Neo-) adjuvant Therapy in Rectal Cancer? A Systematic Review and Meta-analysis

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2008, Elsevier

    PhD Giuseppe Cabibbo

  62. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

    Article • Digestive and Liver Disease, August 2008, Elsevier

    PhD Giuseppe Cabibbo

  63. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

    Article • Alimentary Pharmacology & Therapeutics, June 2008, Wiley

    PhD Giuseppe Cabibbo

  64. Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease

    Article • Gastroenterology, June 2008, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  65. The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data

    Article • Cancer Treatment Reviews, December 2007, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO

  66. [257] MORTALITY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA PREDICTED BY SIX SCORING SYSTEMS: NONE IS THE WINNER

    Article • Journal of Hepatology, April 2007, Elsevier

    PhD Giuseppe Cabibbo

  67. Mortality in patients with hepatocellular carcinoma predicted by six scoring systems: None is the winner

    Article • Digestive and Liver Disease, March 2007, Elsevier

    PhD Giuseppe Cabibbo, Dr GIUSEPPE CABIBBO